Cargando…
Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection
Aged population with comorbidities demonstrated high mortality rate and severe clinical outcome in the patients with coronavirus disease 2019 (COVID-19). However, whether age-adjusted Charlson comorbidity index score (CCIS) predict fatal outcomes remains uncertain. This retrospective, nationwide coh...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104192/ https://www.ncbi.nlm.nih.gov/pubmed/33951004 http://dx.doi.org/10.1097/MD.0000000000025900 |
_version_ | 1783689440739196928 |
---|---|
author | Kim, Do Hyoung Park, Hayne Cho Cho, Ajin Kim, Juhee Yun, Kyu-sang Kim, Jinseog Lee, Young-Ki |
author_facet | Kim, Do Hyoung Park, Hayne Cho Cho, Ajin Kim, Juhee Yun, Kyu-sang Kim, Jinseog Lee, Young-Ki |
author_sort | Kim, Do Hyoung |
collection | PubMed |
description | Aged population with comorbidities demonstrated high mortality rate and severe clinical outcome in the patients with coronavirus disease 2019 (COVID-19). However, whether age-adjusted Charlson comorbidity index score (CCIS) predict fatal outcomes remains uncertain. This retrospective, nationwide cohort study was performed to evaluate patient mortality and clinical outcome according to CCIS among the hospitalized patients with COVID-19 infection. We included 5621 patients who had been discharged from isolation or had died from COVID-19 by April 30, 2020. The primary outcome was composites of death, admission to intensive care unit, use of mechanical ventilator or extracorporeal membrane oxygenation. The secondary outcome was mortality. Multivariate Cox proportional hazard model was used to evaluate CCIS as the independent risk factor for death. Among 5621 patients, the high CCIS (≥ 3) group showed higher proportion of elderly population and lower plasma hemoglobin and lower lymphocyte and platelet counts. The high CCIS group was an independent risk factor for composite outcome (HR 3.63, 95% CI 2.45–5.37, P < .001) and patient mortality (HR 22.96, 95% CI 7.20–73.24, P < .001). The nomogram showed that CCIS was the most important factor contributing to the prognosis followed by the presence of dyspnea (hazard ratio [HR] 2.88, 95% confidence interval [CI] 2.16–3.83), low body mass index < 18.5 kg/m(2) (HR 2.36, CI 1.49–3.75), lymphopenia (<0.8 x10(9)/L) (HR 2.15, CI 1.59–2.91), thrombocytopenia (<150.0 x10(9)/L) (HR 1.29, CI 0.94–1.78), anemia (<12.0 g/dL) (HR 1.80, CI 1.33–2.43), and male sex (HR 1.76, CI 1.32–2.34). The nomogram demonstrated that the CCIS was the most potent predictive factor for patient mortality. The predictive nomogram using CCIS for the hospitalized patients with COVID-19 may help clinicians to triage the high-risk population and to concentrate limited resources to manage them. |
format | Online Article Text |
id | pubmed-8104192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81041922021-05-10 Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection Kim, Do Hyoung Park, Hayne Cho Cho, Ajin Kim, Juhee Yun, Kyu-sang Kim, Jinseog Lee, Young-Ki Medicine (Baltimore) 4900 Aged population with comorbidities demonstrated high mortality rate and severe clinical outcome in the patients with coronavirus disease 2019 (COVID-19). However, whether age-adjusted Charlson comorbidity index score (CCIS) predict fatal outcomes remains uncertain. This retrospective, nationwide cohort study was performed to evaluate patient mortality and clinical outcome according to CCIS among the hospitalized patients with COVID-19 infection. We included 5621 patients who had been discharged from isolation or had died from COVID-19 by April 30, 2020. The primary outcome was composites of death, admission to intensive care unit, use of mechanical ventilator or extracorporeal membrane oxygenation. The secondary outcome was mortality. Multivariate Cox proportional hazard model was used to evaluate CCIS as the independent risk factor for death. Among 5621 patients, the high CCIS (≥ 3) group showed higher proportion of elderly population and lower plasma hemoglobin and lower lymphocyte and platelet counts. The high CCIS group was an independent risk factor for composite outcome (HR 3.63, 95% CI 2.45–5.37, P < .001) and patient mortality (HR 22.96, 95% CI 7.20–73.24, P < .001). The nomogram showed that CCIS was the most important factor contributing to the prognosis followed by the presence of dyspnea (hazard ratio [HR] 2.88, 95% confidence interval [CI] 2.16–3.83), low body mass index < 18.5 kg/m(2) (HR 2.36, CI 1.49–3.75), lymphopenia (<0.8 x10(9)/L) (HR 2.15, CI 1.59–2.91), thrombocytopenia (<150.0 x10(9)/L) (HR 1.29, CI 0.94–1.78), anemia (<12.0 g/dL) (HR 1.80, CI 1.33–2.43), and male sex (HR 1.76, CI 1.32–2.34). The nomogram demonstrated that the CCIS was the most potent predictive factor for patient mortality. The predictive nomogram using CCIS for the hospitalized patients with COVID-19 may help clinicians to triage the high-risk population and to concentrate limited resources to manage them. Lippincott Williams & Wilkins 2021-05-07 /pmc/articles/PMC8104192/ /pubmed/33951004 http://dx.doi.org/10.1097/MD.0000000000025900 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | 4900 Kim, Do Hyoung Park, Hayne Cho Cho, Ajin Kim, Juhee Yun, Kyu-sang Kim, Jinseog Lee, Young-Ki Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection |
title | Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection |
title_full | Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection |
title_fullStr | Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection |
title_full_unstemmed | Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection |
title_short | Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection |
title_sort | age-adjusted charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with covid-19 infection |
topic | 4900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104192/ https://www.ncbi.nlm.nih.gov/pubmed/33951004 http://dx.doi.org/10.1097/MD.0000000000025900 |
work_keys_str_mv | AT kimdohyoung ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection AT parkhaynecho ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection AT choajin ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection AT kimjuhee ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection AT yunkyusang ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection AT kimjinseog ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection AT leeyoungki ageadjustedcharlsoncomorbidityindexscoreisthebestpredictorforsevereclinicaloutcomeinthehospitalizedpatientswithcovid19infection |